AngioDynamics, Inc. (ANGO) Gross Margin
- Gross margin · 12 months: Value 54.62%; Formula and calculation Gross profit / revenue. Period ending 2026-05-31..
Gross margin
Overview →Financial period ending 2026-05-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 54.62% | Gross profit / revenue. Period ending 2026-05-31. $174.89M ÷ $320.17M × 100 ≈ 54.62% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 174.89M USD | Gross Profit |
| Revenue | 320.17M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 145.28M USD | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-05-31 | $174.89M | $320.17M | $145.28M | 54.62% |
| 2026-02-28 | $170.34M | $313.73M | $143.39M | 54.30% |
| 2025-11-30 | $167.72M | $307.31M | $139.59M | 54.58% |
| 2025-08-31 | $162.84M | $300.72M | $137.88M | 54.15% |
| 2025-05-31 | $157.71M | $292.50M | $134.79M | 53.92% |
| 2025-02-28 | $154.00M | $283.32M | $129.32M | 54.36% |
| 2024-11-30 | $151.01M | $286.50M | $135.49M | 52.71% |
| 2024-08-31 | $151.36M | $292.73M | $141.36M | 51.71% |
| 2024-05-31 | $154.70M | $303.91M | $149.22M | 50.90% |
| 2024-02-29 | $162.54M | $324.01M | $161.47M | 50.17% |
| 2023-11-30 | $167.19M | $329.54M | $162.35M | 50.73% |
| 2023-08-31 | $172.00M | $335.89M | $163.89M | 51.21% |
| 2023-05-31 | $174.25M | $338.75M | $164.51M | 51.44% |
| 2023-02-28 | $174.34M | $334.68M | $160.33M | 52.09% |
| 2022-11-30 | $172.42M | $327.93M | $155.51M | 52.58% |
| 2022-08-31 | $167.90M | $320.79M | $152.89M | 52.34% |
| 2022-05-31 | $165.73M | $316.22M | $150.49M | 52.41% |
| 2022-02-28 | $161.60M | $306.06M | $144.47M | 52.80% |
| 2021-11-30 | $161.54M | $303.27M | $141.73M | 53.27% |
| 2021-08-31 | $161.16M | $297.76M | $136.60M | 54.12% |
| 2021-05-31 | $156.79M | $291.01M | $134.22M | 53.88% |
| 2021-02-28 | $144.68M | $272.50M | $127.82M | 53.09% |
| 2020-11-30 | $146.45M | $271.10M | $124.65M | 54.02% |
| 2020-08-31 | $147.82M | $268.33M | $120.51M | 55.09% |
| 2020-05-31 | $150.27M | $264.16M | $113.89M | 56.89% |
| 2020-02-29 | $161.39M | $277.01M | $115.62M | 58.26% |
| 2019-11-30 | $159.26M | $272.75M | $113.50M | 58.39% |
| 2019-08-31 | $158.26M | $272.73M | $114.47M | 58.03% |
| 2019-05-31 | $156.00M | $270.63M | $114.63M | 57.64% |
| 2019-02-28 | $187.73M | $351.50M | $163.77M | 53.41% |
| 2018-11-30 | $186.49M | $349.01M | $162.52M | 53.43% |
| 2018-08-31 | $180.11M | $344.21M | $164.10M | 52.33% |
| 2018-05-31 | $176.88M | $344.29M | $167.41M | 51.37% |
| 2018-02-28 | $171.74M | $342.88M | (m) | 50.09% |
| 2017-11-30 | $170.09M | $344.63M | (m) | 49.35% |
| 2017-08-31 | $172.37M | $346.96M | (m) | 49.68% |
| 2017-05-31 | $176.17M | $349.64M | (m) | 50.39% |
| 2017-02-28 | $175.36M | $356.15M | (m) | 49.24% |
| 2016-11-30 | $175.10M | $357.98M | (m) | 48.91% |
| 2016-08-31 | $175.98M | $358.24M | (m) | 49.12% |
| 2016-05-31 | $174.32M | $353.89M | (m) | 49.26% |
| 2016-02-29 | $178.05M | $351.22M | (m) | 50.69% |
| 2015-11-30 | $172.42M | $350.43M | (m) | 49.20% |
| 2015-08-31 | $174.24M | $353.35M | (m) | 49.31% |
| 2015-05-31 | $176.89M | $356.97M | (m) | 49.55% |
| 2015-02-28 | $178.74M | $360.14M | (m) | 49.63% |
| 2014-11-30 | $185.68M | $361.69M | (m) | 51.34% |
| 2014-08-31 | $182.91M | $358.11M | (m) | 51.08% |
| 2014-05-31 | $179.86M | $354.45M | (m) | 50.74% |
| 2014-02-28 | $177.29M | $350.42M | (m) | 50.59% |
| 2013-11-30 | $172.85M | $343.80M | (m) | 50.28% |
| 2013-08-31 | $172.01M | $342.20M | (m) | 50.27% |
| 2013-05-31 | $168.99M | $342.03M | (m) | 49.41% |
| 2013-02-28 | $155.91M | $309.68M | (m) | 50.35% |
| 2012-11-30 | $144.13M | $279.68M | (m) | 51.53% |
| 2012-08-31 | $133.27M | $250.76M | (m) | 53.15% |
| 2012-05-31 | $125.96M | $221.79M | (m) | 56.79% |
| 2012-02-29 | (m) | (m) | (m) | (m) |
| 2011-11-30 | (m) | (m) | (m) | (m) |
| 2011-08-31 | (m) | (m) | (m) | (m) |
| 2011-08-30 | $127.83M | $218.67M | (m) | 58.46% |
| 2011-05-31 | $125.70M | $215.75M | (m) | 58.26% |
| 2011-02-28 | (m) | (m) | (m) | (m) |
| 2010-11-30 | (m) | (m) | (m) | (m) |
| 2010-08-31 | (m) | (m) | (m) | (m) |
| 2010-05-31 | $126.97M | $216.03M | (m) | 58.77% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |